Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: DEO stock price vs BMRN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BMRN's multiple
Needs BMRN P/E.
Implied fair value · at DEO's multiple
Needs DEO P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: DEO FY 2025 (ended Jun 30, 2025) · BMRN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
DIAGEO plc · implied price per share
Bear
-$12.29
Base
-$14.46
Bull
-$16.63
BIOMARIN PHARMACEUTICAL INC · implied price per share
Bear
$25.74
Base
$30.28
Bull
$34.82
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
—
0.06x
Net debt / EBITDA
Leverage against operating earnings
8.42x
-3.03x
Cash and equivalents
Liquid reserves on the balance sheet
$2.20B
$2.11B
Total debt
Interest-bearing obligations outstanding
$33.20B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CONSTELLATION BRANDS, INC.
DEO vs STZ
COCA COLA CO
DEO vs KO
PEPSICO INC
DEO vs PEP
MOLSON COORS BEVERAGE CO
DEO vs TAP
BOSTON BEER CO INC
DEO vs SAM
VERTEX PHARMACEUTICALS INC / MA
DEO vs VRTX
ALNYLAM PHARMACEUTICALS, INC.
DEO vs ALNY
Sarepta Therapeutics, Inc.
DEO vs SRPT
REGENXBIO Inc.
DEO vs RGNX
IONIS PHARMACEUTICALS INC
DEO vs IONS
PTC THERAPEUTICS, INC.
DEO vs PTCT
$347.22M
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
